- Research team: Principal investigator Janet H. Van Cleave, PhD, RN, FAAN. Site principal investigators Abraham A. Brody, PhD, RN, FAAN, NYU Meyers College of Nursing; Kenneth S. Hu, MD, NYU Grossman School of Medicine and NYU Perlmutter Cancer Center; Jessica R. Bauman, MD, Fox Chase Cancer Center; and Christopher E. Lominska, MD, the University of Kansas Cancer Center; Brian L. Egleston, MPP, PhD, Fox Chase Cancer Center, will serve as biostatistician for the project.
- Funding sponsor: National Cancer Institute (NCI)
- Overview: This study will investigate the implementation and effectiveness of a patient-reported symptom tool for head and neck cancers. Learn more.
- Budget: $733,528
- Project period: Sept. 19, 2023, through Aug. 31, 2025